BiomedicalPublications

What DOAJ, PubMed and Scopus indexing actually means (and doesn't)

“Indexed in” is the most quoted credential in scholarly publishing and the least understood. Each registry applies a different test, and none of them is a quality audit of the articles.

Of the 11,447 journals we track, 3,620 have a full DOAJ record. The remainder are mostly subscription titles, which DOAJ does not cover by design — not journals that failed a test.

DOAJ: a disclosure test, not a quality test

The Directory of Open Access Journals lists open-access journals that complete a detailed application. Reviewers check that the journal has a verifiable ISSN, a named editorial board with affiliations, a stated peer-review model, a clearly published licence, and — importantly — publication charges stated openly before submission.

What DOAJ is really testing is disclosure: does this journal say, in public and in advance, how it operates? That is genuinely valuable, and it is why a DOAJ record is the source of most editorial metadata on our journal pages — review model, licence, copyright retention, archiving policy.

What it does not tell you: whether the declared peer review actually happens as described. DOAJ checks that a policy is stated, not that it is followed. Journals are removed when problems come to light, but removal is reactive.

Absence proves little. DOAJ only lists open-access journals, so every subscription journal in the world is missing from it, including many of the oldest and most respected titles in medicine.

PubMed: three different things with one name

This is where most misleading claims live, because “in PubMed” can mean three quite different things.

A journal claiming “PubMed indexed” while meaning the second or third is making a technically defensible statement designed to be misread. Check which one applies in the NLM Catalog: the record states MEDLINE status explicitly.

Scopus: broad coverage, periodic re-evaluation

Scopus is Elsevier's abstract and citation database. Titles are assessed by an independent Content Selection and Advisory Board against criteria covering peer-review policy, editorial quality, regularity of publication, English abstracts and citedness. Coverage is broader than MEDLINE or Web of Science, which is both its strength and the reason inclusion says less.

Scopus does re-evaluate and does discontinue titles that stop meeting the criteria — a real advantage over registries that only ever add. But it is a commercial database owned by a major publisher, and CiteScore is computed from it, which is worth remembering when a journal quotes both.

Web of Science and the Impact Factor

Clarivate's Web of Science is the most selective of the general databases, and selection into its core collections is what makes a Journal Impact Factor possible. Inclusion is a meaningful signal; absence is common among perfectly good specialist and regional journals.

Why indexing is a floor, not a guarantee

Every registry above tests the journal's stated process, at the moment of assessment. None re-reads the articles. None can detect a journal that passed review in 2019 and was sold in 2023 to an operator running it differently. Indexing tells you a journal cleared a bar once and has not yet been removed.

Used correctly, indexing answers a narrow question well: will this paper be findable by the people who need it, and will it count where I am assessed? For most researchers that is the practical reason indexing matters at all.

How to check, in practice

Our journal check runs the registry lookups automatically across 11,447 journals and shows you which records exist, with links to each source so you can verify any of it yourself.

Regional and specialist indexes

The four databases above are not the whole map, and treating them as such systematically undervalues research published outside North America and Western Europe. SciELO covers Latin America, Spain, Portugal and South Africa; LILACS covers health sciences across Latin America and the Caribbean; African Journals Online and the Directory of Open Access Scholarly Resources cover territory the large commercial databases barely touch.

A journal indexed in SciELO but not Scopus is not thereby suspect. It may be an established national title serving a readership the commercial databases have never prioritised. The 133 countries represented across our directory include a great many journals in exactly that position.

Field-specific indexes matter too: Embase for pharmacology and biomedical research, CINAHL for nursing and allied health, PsycINFO for psychology. For some assessment frameworks these count for more than a general database.

Delisting: the signal people miss

Registries remove journals, and removal is far more informative than inclusion. DOAJ has run large-scale reviews that removed thousands of titles for failing to meet updated criteria or failing to reapply. Scopus discontinues titles that fall below its quality thresholds and publishes the list. Web of Science delists titles, sometimes for citation manipulation.

The practical consequence: a journal's claim to be indexed may have been true when the badge was made. Check the registry as it is today, and if a journal was removed, find out why. A title that was delisted and quietly kept the logo has told you something important about its honesty.

If a journal is not indexed anywhere

Absence is not proof of anything on its own, and there are honest explanations: the journal is new, very small, regional, or publishes outside biomedicine. Newly launched journals commonly need two to three years of consistent output before they can even apply to the major databases.

What matters is whether the other checks fail at the same time. A new journal with a verifiable ISSN, a real named board, a published fee and a declared review model is a reasonable risk. One with none of those and no index record is not a risk, it is an answer. Work through the seven-step check and count the failures.